Literature DB >> 15277485

Alkylphosphocholines: a new therapeutic option in glaucoma filtration surgery.

Kirsten H Eibl1, Bernhard Banas, Daniel Kook, Anne V Ohlmann, Siegfried Priglinger, Anselm Kampik, Ulrich C Welge-Luessen.   

Abstract

PURPOSE: To investigate the effect of alkylphosphocholines (APCs) on human Tenon fibroblast (HTF) proliferation, migration, and cell-mediated collagen gel contraction.
METHODS: HTFs were isolated from tissue samples of three patients obtained during surgery and cultured in DMEM and 10% fetal calf serum (FCS). HTFs (passage 3-6) were treated with one APC in different concentrations spanning the 50% inhibitory concentration (IC(50)), as determined previously. Inhibition of cell proliferation was assessed by the tetrazolium dye reduction assay. Migration was determined in chemoattractant chambers with fibronectin-coated polycarbonated membranes. For inhibition of contraction, three-dimensional collagen gels were seeded with HTFs, and the gel size was measured. Cell viability was determined by the trypan blue exclusion assay. For analysis of the mechanism of action, protein kinase C (PKC) activity was measured.
RESULTS: The IC(50) varied between 7.0 and 10.5 microM for all APCs tested. At this concentration, all four APCs inhibited HTF migration and cell-mediated collagen gel contraction in the presence of serum. The inhibitory effects on HTF proliferation, migration, and contraction were observed at nontoxic concentrations. PKC activity was reduced to 50% of control level at the IC(50) of all APCs applied.
CONCLUSIONS: APCs are effective inhibitors of HTF proliferation, migration, and cell-mediated contraction of collagen gels at nontoxic concentrations. Their mechanism of action seems to involve the inhibition of the PKC pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277485     DOI: 10.1167/iovs.03-1351

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

1.  [Alkylphosphocholines inhibit lens epithelial cell proliferation and attachment].

Authors:  R Liegl; M Kernt; K Obholzer; A Wolf; R Schumann; C Haritoglou; A Kampik; K H Eibl-Lindner
Journal:  Ophthalmologe       Date:  2010-10       Impact factor: 1.059

2.  The safety profile of alkylphosphocholines in the model of the isolated perfused vertebrate retina.

Authors:  Matthias Lüke; Kai Januschowski; Julia Lüke; Salvatore Grisanti; Peter Szurman; Klaus Dietz; Anselm Kampik; Karl Ulrich Bartz-Schmidt; Kirsten H Eibl-Lindner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-20       Impact factor: 3.117

3.  Attenuation of human lens epithelial cell spreading, migration and contraction via downregulation of the PI3K/Akt pathway.

Authors:  R Liegl; C Wertheimer; M Kernt; D Docheva; A Kampik; K H Eibl-Lindner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-22       Impact factor: 3.117

4.  A Pilot Study on Ocular Safety and Efficacy of Infliximab as an Antifibrotic Agent After Experimental Glaucoma Filtration Surgery.

Authors:  Eleni Nikita; Alexandre Moulin; Ioannis Vergados; Dimitrios Brouzas; Panagiotis G Theodossiadis
Journal:  Ophthalmol Ther       Date:  2017-07-01

5.  Functional proteomics of failed filtering blebs.

Authors:  Takashi Kanamoto; Nazariy Souchelnytskyi; Yoshiaki Kiuchi
Journal:  Mol Vis       Date:  2009-12-15       Impact factor: 2.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.